News in brief: Most newly diagnosed HCV patients go untreated; Cap-assisted endoscopy best for removal of impacted oesophageal FB; COVID-19 vax booster to be recommended for immunocompromised patients

Most newly diagnosed HCV patients not treated: study Less than half of patients (47%) newly diagnosed with hepatitis C virus (HCV) who are eligible for antiviral treatment received such treatment in the 12 months after diagnosis, a study from NSW has found. A review of 200 HCV notifications from 2017 found that of the 79 ...

Already a member?

Login to keep reading.

© 2021 the limbic